Literature DB >> 12933790

Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE).

Janet A Weigel1, Paul H Weigel.   

Abstract

Hyaluronan (HA) and chondroitin sulfate (CS) clearance from lymph and blood in mammals is mediated by the HA receptor for endocytosis (HARE), which is present as two isoforms in rat and human (175/300 kDa and 190/315 kDa, respectively) in the sinusoidal endothelial cells of liver, spleen, and lymph nodes (Zhou, B., McGary, C. T., Weigel, J. A., Saxena, A., and Weigel, P. H. (2003) Glycobiology 13, 339-349). The small rat and human HARE proteins are not encoded directly by mRNA but are derived from larger precursors. Here we characterize the specificity and function of the 175-kDa HARE, expressed in the absence of the 300-kDa species, in stably transfected SK-Hep-1 cells. The HARE cDNA was fused with a leader sequence to allow correct orientation of the membrane protein. The recombinant rHARE contained approximately 25 kDa of N-linked oligosaccharides and, like the native protein, was able to bind HA in a ligand blot assay, even after de-N-glycosylation. SK-HARE cell lines demonstrated specific 125I-HA endocytosis, receptor recycling, and delivery of HA to lysosomes for degradation. The Kd for the binding of HA (number-average molecular mass approximately 133 kDa) to the 175-kDa HARE at 4 degrees C was 4.1 nm with 160,000 to 220,000 HA-binding sites per cell. The 175-kDa rHARE binds HA, dermatan sulfate, and chondroitin sulfates A, C, D, and E, but not chondroitin, heparin, heparan sulfate, or keratan sulfate. Surprisingly, recognition of glycosaminoglycans (GAGs) other than HA by native or recombinant HARE was temperature-dependent. Although competition was observed at 37 degrees C, none of the other GAGs competed for 125I-HA binding to SK-HARE cells at 4 degrees C. Anti-HARE monoclonal antibody-174 showed a similar temperature-dependence in its ability to block HA endocytosis. These data suggest that temperature-induced conformational changes may alter the GAG specificity of HARE. The results confirm that the 175-kDa rHARE does not require the larger HARE isoform to mediate endocytosis of multiple GAGs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933790     DOI: 10.1074/jbc.M307201200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis.

Authors:  Brian P Teng; Melissa D Heffler; Eric C Lai; Ya-Li Zhao; Charles M LeVea; Vita M Golubovskaya; Kelli M Bullarddunn
Journal:  Anticancer Agents Med Chem       Date:  2011-09       Impact factor: 2.505

2.  N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronan.

Authors:  Edward N Harris; Simon Parry; Mark Sutton-Smith; Madhu S Pandey; Maria Panico; Howard R Morris; Stuart M Haslam; Anne Dell; Paul H Weigel
Journal:  Glycobiology       Date:  2010-04-14       Impact factor: 4.313

3.  Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.

Authors:  Hussaini Syed Sha Qhattal; Xinli Liu
Journal:  Mol Pharm       Date:  2011-07-05       Impact factor: 4.939

Review 4.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

6.  The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization.

Authors:  Madhu S Pandey; Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

7.  The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.

Authors:  Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

Review 8.  Stabilin-1, a homeostatic scavenger receptor with multiple functions.

Authors:  Julia Kzhyshkowska; A Gratchev; S Goerdt
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

9.  Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration.

Authors:  Seung-Yoon Park; Youngeun Yun; Jung-Suk Lim; Mi-Jin Kim; Sang-Yeob Kim; Jung-Eun Kim; In-San Kim
Journal:  Nat Commun       Date:  2016-03-14       Impact factor: 14.919

10.  Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance Receptor.

Authors:  Hans Gaus; Colton M Miller; Punit P Seth; Edward N Harris
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.